The scientist’s investigation covers issues in Immunology, Internal medicine, Antiphospholipid syndrome, Pregnancy and Antibody. The various areas that Angela Tincani examines in her Immunology study include Endothelial stem cell, MEDLINE and Family medicine. Her study ties her expertise on Endocrinology together with the subject of Internal medicine.
Her study in Antiphospholipid syndrome is interdisciplinary in nature, drawing from both Lupus anticoagulant, Intensive care medicine and Platelet. Her work deals with themes such as Retrospective cohort study, Prospective cohort study, Pediatrics and Obstetrics, which intersect with Pregnancy. Her research integrates issues of Flow cytometry and Macrophage, Apoptotic cell clearance in her study of Antibody.
Angela Tincani mainly focuses on Immunology, Internal medicine, Antibody, Pregnancy and Antiphospholipid syndrome. As a member of one scientific family, Angela Tincani mostly works in the field of Immunology, focusing on Systemic lupus erythematosus and, on occasion, Lupus nephritis. Her Internal medicine research includes elements of Gastroenterology and Endocrinology.
Angela Tincani has included themes like Antigen and Pathology in her Antibody study. Her Pregnancy study integrates concerns from other disciplines, such as Prospective cohort study, Disease, Pediatrics and Obstetrics. Her Antiphospholipid syndrome research is multidisciplinary, relying on both Lupus anticoagulant and Intensive care medicine.
Angela Tincani focuses on Internal medicine, Pregnancy, Cohort, Pediatrics and Disease. Her research in Internal medicine intersects with topics in Gastroenterology and Antibody. Her Antibody research is under the purview of Immunology.
Her Pregnancy research incorporates elements of Rheumatoid arthritis, Retrospective cohort study and Obstetrics. In her research on the topic of Disease, Disease activity and Lupus erythematosus is strongly related with Intensive care medicine. The Antiphospholipid syndrome study combines topics in areas such as Autoimmune disease and Anti-thyroid autoantibodies.
Her primary scientific interests are in Internal medicine, Disease, Pregnancy, Antiphospholipid syndrome and Immunology. In general Internal medicine, her work in Rheumatology, Hydroxychloroquine, Cohort and Multivariate analysis is often linked to In patient linking many areas of study. Her Disease research is multidisciplinary, incorporating elements of Arthritis, Rheumatoid arthritis and Intensive care medicine.
Her Pregnancy research integrates issues from Low molecular weight heparin, Retrospective cohort study, Pediatrics and Univariate analysis. Antiphospholipid syndrome is a subfield of Thrombosis that Angela Tincani explores. She interconnects Healthy subjects, Relapsing course and Haplotype in the investigation of issues within Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
S. Miyakis;M. D. Lockshin;T. Atsumi;D. W. Branch.
Journal of Thrombosis and Haemostasis (2006)
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Ricard Cervera;Jean Charles Piette;Josep Font;Munther A. Khamashta.
Arthritis & Rheumatism (2002)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
G. Bertsias;J. P. A. Ioannidis;J. Boletis;S. Bombardieri.
Annals of the Rheumatic Diseases (2008)
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
G K Bertsias;J P A Ioannidis;M Aringer;E Bollen.
Annals of the Rheumatic Diseases (2010)
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.
Jean Claude Souberbielle;Jean Jacques Body;Joan M. Lappe;Mario Plebani.
Autoimmunity Reviews (2010)
The EULAR Points to Consider for Use of Antirheumatic Drugs Before Pregnancy, and During Pregnancy and Lactation
Carina Götestam Skorpen;Maria Hoeltzenbein;Angela Tincani;Rebecca Fischer-Betz.
Annals of the Rheumatic Diseases (2016)
Anti-inflammatory and immunosuppressive drugs and reproduction.
Monika Østensen;Munther Khamashta;Michael Lockshin;Ann Parke.
Arthritis Research & Therapy (2006)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Antonis Fanouriakis;Myrto Kostopoulou;Alessia Alunno;Martin Aringer.
Annals of the Rheumatic Diseases (2019)
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women
Antonio Brucato;Micol Frassi;Franco Franceschini;Rolando Cimaz.
Arthritis & Rheumatism (2001)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera;M. A. Khamashta;Y. Shoenfeld;M. T. Camps.
Annals of the Rheumatic Diseases (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: